These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5442024)

  • 1. Field techniques in the diagnosis of kala-azar.
    Cahill KM
    Trans R Soc Trop Med Hyg; 1970; 64(1):107-10. PubMed ID: 5442024
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmanin test in post-kala-azar dermal leishmaniasis.
    Neogy AB; Nandy A; Chowdhury AB
    Trans R Soc Trop Med Hyg; 1990; 84(1):58. PubMed ID: 2345927
    [No Abstract]   [Full Text] [Related]  

  • 3. Widal reaction in Kala-azar.
    Singh UK; Sinha RK; Sharma VK
    Indian Pediatr; 1995 Jun; 32(6):680-3. PubMed ID: 8613339
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S; Malakar S
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response in Indian kala-azar.
    Aikat BK; Pathania AG; Sehgal S; Bhattacharya PK; Dutta U; Pasricha N; Singh S; Parmar RS; Sahaya S; Prasad LS
    Indian J Med Res; 1979 Oct; 70():583-91. PubMed ID: 396234
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma as a cause of false positive serology for visceral leishmaniasis (kala-azar) using the indirect haemagglutination (IHA) method.
    Malik GM; Abdalla RE; al-Knawy B; Abdalla SE
    J Trop Med Hyg; 1995 Aug; 98(4):285-6. PubMed ID: 7636928
    [No Abstract]   [Full Text] [Related]  

  • 10. False positive serology for visceral leishmanias (kala-azar) using the indirect haemagglutination (IHA) method.
    Malik GM; Reshi SH; Abdalla SE
    J Trop Med Hyg; 1992 Feb; 95(1):67-70. PubMed ID: 1740822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment].
    Mayrink W; Magalhàes PA; Batista SM; da Costa CA
    Rev Inst Med Trop Sao Paulo; 1971; 13(4):268-71. PubMed ID: 5132387
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of different saprophytic acid-fast bacilli in complement-fixation test for kala-azar.
    Rahman KM
    Bangladesh Med Res Counc Bull; 1975 Apr; 1(1):32-8. PubMed ID: 1244012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.
    Bern C; Amann J; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Wagatsuma Y; Breiman RF; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2006 Oct; 75(4):744-8. PubMed ID: 17038705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmanin test in Indian kala-azar.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Trans R Soc Trop Med Hyg; 1986; 80(3):454-5. PubMed ID: 3798542
    [No Abstract]   [Full Text] [Related]  

  • 15. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cell-mediated immunity in patients with kala-azar.
    Hepner Levy L; Mendes E
    Allergol Immunopathol (Madr); 1981; 9(2):109-12. PubMed ID: 7293874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions].
    Frances C; Merle Beral H; Franceschini P; Lessana-Leibowitch M; Escande JP
    Presse Med; 1984 Nov; 13(40):2433-6. PubMed ID: 6239222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania donovani donovani and Leishmania donovani chagasi as antigens in a direct agglutination assay for the diagnosis of kala-azar.
    Andrade CR; Nascimento AE; Moura PM; Andrade PP
    Braz J Med Biol Res; 1989; 22(5):611-5. PubMed ID: 2620171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.